|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 365.80 CHF | +12.94% |
|
0.00% | +11.81% |
| 07-27 | Sika raises annual sales-growth outlook after strong first-half performance | RE |
| 07-27 | IDEAYA Biosciences Advances IDE892 Into Phase 1/2 Monotherapy Expansion | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- ROP Stock
- 0QOK Stock
- Consensus Roche Holding AG
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
